valueequityanalysis.com

Independent, business-by-business valuations built from company filings — owner earnings, a ten-year outlook, and a bear / base / bull range. Search a ticker to see our estimate of what the business is worth.

Not investment advice. We are not registered investment advisers, and the people behind this site may hold or trade positions in companies analyzed here. Full disclosures.

GLOBE LIFE INC. (GL) stock intrinsic value fair value estimate & owner earnings analysis

Margin of safety$110.00 ComplexityAverage Updated
$178.00 $280.00
bear $178.00 base $240.00 bull $280.00 margin of safety $110.00 market price* $168.77
Globe Life sells small life insurance and supplemental health policies, mostly to middle-income and union families, through its own exclusive agent networks: American Income Life (about 53% of life premium), Liberty National, Family Heritage, a direct-to-consumer arm and the Medicare supplement business United American. Premiums renew year after year, and total premium grew 5% in 2025 to about $5 billion. Roughly 2% of the $20.5 billion investment portfolio is rated below investment grade. Cash from operations has stayed between $1.28 billion and $1.48 billion in each of the last ten years, including the 2020 shutdown. How we measure earnings. For an insurer, growth in policy reserves and the up-front commissions that are capitalised and amortised are the normal working capital of the business, so we strip those timing items out, then deduct stock compensation and the capital spending needed to stay in business, while adding back non-cash investment gains and losses. On that basis owner earnings were about $1.0 billion in 2025 ($12.05 per share). Two judgements matter. First, a 2023 accounting change (applied back to 2021) lowered the amortisation of acquisition costs and raised reported profit by roughly a third, so earlier years are not comparable and we measure only from 2021. Second, 2025 capital spending of $142 million was double 2024; first-half 2026 spending ran at about half that pace, so we do not treat 2025 as the new normal. We anchor on the middle of 2021-2025 owner earnings, about $969 million a year, which is about $12.29 per share on the roughly 78.9 million diluted shares outstanding in mid-2026. We deliberately state the anchor in total dollars and divide by today's share count: buybacks already done are permanent, but the per-share growth of 11% in 2025 (from $10.81 to $12.05) came mostly from fewer shares, while total owner earnings grew only 2.6%. We therefore start the base case at 2.5% growth in the first year, not at the per-share rate. Borrowings are modest for an insurer: about $2.66 billion face value, mostly senior notes plus $306 million of commercial paper (a term loan and notes mature in 2027 and 2028). Interest of about $145 million a year is already deducted in the earnings above and the borrowings are the company's funding, so we do not subtract them a second time. In each case below, the business is worth the figure stated and the debt is paid out of its earnings rather than deducted again. Base case: about $240 per share (roughly $19 billion). Owner earnings grow 2.5% a year for five years, then 2%, 1.5%, 1% and 0.5%, reaching about $1.18 billion by year ten, then stay flat. What we credit: the agent-driven sales engine that has grown revenue about 4.8% a year since 2016, through the 2020 shutdown, funded from the company's own cash. We credit less than that, and taper it, because the American Income Life agent count fell 7% year on year in the second quarter of 2026. Management expects mid-single-digit agent growth in the second half; we leave that out because it has not happened yet. We also leave out management's expectation of $110-130 million of one-time gains from third-quarter actuarial updates, the better health claims experience (the health underwriting margin actually slipped to 23% from 26% a year earlier), and any gain from share repurchases beyond today's share count. Bear case: about $178 per share (roughly $14 billion). Owner earnings stay flat at about $969 million for two years, with no growth at all because recruiting does not recover. Then two named problems arrive. First, the Equal Employment Opportunity Commission found reasonable cause to believe that a group of American Income agents should be treated as employees; the conciliation ended without agreement in October 2024, and the agency has not communicated since but could still sue. If agents had to be treated as employees, payroll taxes and benefits on roughly $1 billion of agent compensation would cut owner earnings about 12% permanently (to about $853 million). Second, one full credit cycle on the $20.5 billion portfolio, sized from Torchmark (the company's predecessor name) in 2008: in the third quarter of 2008 alone it wrote off about $93 million on Lehman, Washington Mutual and Fannie Mae preferred holdings, about 1.2% of its portfolio in one quarter. We use total after-tax losses of about 3% of the portfolio, about $485 million spread over two years, which cuts owner earnings to about $610 million for those two years before returning to $853 million. Capital stays well above what is needed, so no stock issuance is assumed. Bull case: about $280 per share (roughly $22 billion). The agent networks execute on the levers visible today: Liberty National agents up 8% and Family Heritage agents up 7% in the second quarter, health premiums up 16%, and American Income agent count recovers. Owner earnings grow 3% in year one, then 5% a year (about the company's demonstrated revenue growth) for four years, 4%, 4%, 3%, 3% and 2%, reaching about $1.4 billion in year ten, then flat. What could make this wrong: the biggest unmodelled risks are the employee-classification issue turning into a lawsuit that also forces changes to how agents are paid and recruited (damaging the sales engine itself, not just costing 12%), and the shareholder class action and derivative suits that followed the April 2024 short-seller report (the company is indemnifying the individuals; no loss has been recorded and the potential size cannot be determined from the filings). Annual actuarial assumption updates can also move reported profit either way, and a prolonged fall in agent count would erode the premium growth we credit. How we reached the margin-of-safety price. We are very sure of the earnings level: owner earnings have sat between $933 million and $1,012 million for five years, and operating cash flow has been steady for ten. We are less sure about growth, which depends on agent recruiting that is currently weak in the largest division. The worst plausible event, outside our cases, is the loss of the exclusive-agent model through reclassification or regulation; the business would survive (the policies in force keep renewing and the borrowings are modest) but earnings could be about a third lower and growth would stop. If we are wrong about agents and credit together, the shares would be worth about $120-130. The price assumes a holding period of five years or more. During that period the business pays a small dividend (about $1 a share) and uses most of its owner earnings to retire shares, which shrinks the share count by roughly 4-5% a year. At $110, the anchor owner earnings of $12.29 a share are an 11% annual yield on the price, plus about 2.5% growth, and a rise of the shares to only about 14 times those earnings (around $172, well below our base value) over five years would imply a total return of about 20% a year. The margin-of-safety price is $110 and no higher because the margin for error disappears quickly once the agent-count and classification risks are considered. A previous analysis of this company was prepared on a different basis (profit per share instead of owner earnings after stock compensation and capital spending) and its figures are not comparable. What has changed in the business since then: American Income agent count fell 7% in the second quarter of 2026, health margins slipped, and first-half 2026 net income rose 10% to $558 million. Sources: the 2025 annual report and the second-quarter 2026 filing and call for facts and dates only.
Fiscal yearOwner's earningsMethodology
2025 $12.05 ▼
OE = CFO - dWC - SBC - maintenance capex (insurer treatment: policy liabilities and deferred acquisition costs are the working capital of a life insurer, so their cash-flow-statement movements are removed). CFO=$1396.4M. dWC = increase in future policy benefits 582.1 + other policy benefits 21.1 + deferral of policy acquisition costs (941.9) + DAC amortization 447.8 + change in current/deferred income taxes 98.9 = $208.0M. SBC=$53.4M. Capex=$142.5M (elevated vs $71.0M in 2024; first-half 2026 capex was $41.4M); mean capex/revenue 2016-2025=0.979%; revenue $5994.3M vs prior-year $5778.1M so growth capex=$2.1M and maintenance capex=$140.4M. OE=$994.7M; diluted shares=82.52M; OE/sh=$12.05. Replaces the earlier net-income-basis record (OE = net income/diluted shares = $14.07), which used a different formula than the current method. Source: FY2025 10-K, accession 0000320335-26-000090.
2024 $10.81 ▼
OE = CFO - dWC - SBC - maintenance capex (insurer treatment: policy liabilities and deferred acquisition costs are the working capital of a life insurer, so their cash-flow-statement movements are removed). CFO=$1402.4M. dWC = increase in future policy benefits 731.4 + other policy benefits 19.3 + deferral of policy acquisition costs (913.5) + DAC amortization 410.0 + change in current/deferred income taxes 77.9 = $325.1M. SBC=$40.1M. Capex=$71.0M; mean capex/revenue 2016-2025=0.979%; revenue $5778.1M vs prior-year $5447.5M so growth capex=$3.2M and maintenance capex=$67.8M. OE=$969.4M; diluted shares=89.66M; OE/sh=$10.81. Replaces the earlier net-income-basis record (OE = net income/diluted shares = $11.94), which used a different formula than the current method. Source: FY2025 10-K, accession 0000320335-26-000090.
2023 $9.69 ▼
OE = CFO - dWC - SBC - maintenance capex (insurer treatment: policy liabilities and deferred acquisition costs are the working capital of a life insurer, so their cash-flow-statement movements are removed). CFO=$1482.4M. dWC = increase in future policy benefits 834.4 + other policy benefits 5.4 + deferral of policy acquisition costs (850.2) + DAC amortization 379.7 + change in current/deferred income taxes 101.4 = $470.8M. SBC=$30.7M. Capex=$49.6M; mean capex/revenue 2016-2025=0.979%; revenue $5447.5M vs prior-year $5226.7M so growth capex=$2.2M and maintenance capex=$47.4M. OE=$933.5M; diluted shares=96.36M; OE/sh=$9.69. Replaces the earlier net-income-basis record (OE = net income/diluted shares = $10.07), which used a different formula than the current method. Source: FY2025 10-K, accession 0000320335-26-000090.
2022 $9.63 ▼
OE = CFO - dWC - SBC - maintenance capex (insurer treatment: policy liabilities and deferred acquisition costs are the working capital of a life insurer, so their cash-flow-statement movements are removed). CFO=$1422.2M. dWC = increase in future policy benefits 759.4 + other policy benefits 35.6 + deferral of policy acquisition costs (828.9) + DAC amortization 348.8 + change in current/deferred income taxes 91.8 = $406.8M. SBC=$35.6M. Capex=$27.9M; mean capex/revenue 2016-2025=0.979%; revenue $5226.7M vs prior-year $5112.0M so growth capex=$1.1M and maintenance capex=$26.8M. OE=$953.0M; diluted shares=98.98M; OE/sh=$9.63. Replaces the earlier net-income-basis record (OE = net income/diluted shares = $9.04), which used a different formula than the current method. LDTI-restated basis. Source: FY2024 10-K, accession 0000320335-25-000013.
2021 $9.81 ▼
OE = CFO - dWC - SBC - maintenance capex (insurer treatment: policy liabilities and deferred acquisition costs are the working capital of a life insurer, so their cash-flow-statement movements are removed). CFO=$1437.7M. dWC = increase in future policy benefits 645.9 + other policy benefits 31.5 + deferral of policy acquisition costs (782.5) + DAC amortization 317.6 + change in current/deferred income taxes 148.0 = $360.5M. SBC=$30.3M. Capex=$38.2M; mean capex/revenue 2016-2025=0.979%; revenue $5112.0M vs prior-year $4737.9M so growth capex=$3.7M and maintenance capex=$34.6M. OE=$1012.3M; diluted shares=103.17M; OE/sh=$9.81. Replaces the earlier net-income-basis record (OE = net income/diluted shares = $9.99), which used a different formula than the current method. LDTI (ASU 2018-12) restated basis; not comparable with 2016-2020. Source: FY2023 10-K, accession 0000320335-24-000006.
2020 $6.78 ▼
OE = CFO - dWC - SBC - maintenance capex (insurer treatment: policy liabilities and deferred acquisition costs are the working capital of a life insurer, so their cash-flow-statement movements are removed). CFO=$1476.4M. dWC = increase in future policy benefits 798.9 + other policy benefits 33.8 + deferral of policy acquisition costs (823.0) + DAC amortization 575.8 + change in current/deferred income taxes 88.2 = $673.7M. SBC=$35.9M. Capex=$41.8M; mean capex/revenue 2016-2025=0.979%; revenue $4737.9M vs prior-year $4527.5M so growth capex=$2.1M and maintenance capex=$39.7M. OE=$727.2M; diluted shares=107.22M; OE/sh=$6.78. Pre-LDTI accounting basis; LDTI (ASU 2018-12) applies from 2021, so OE from 2021 onward is not comparable with 2016-2020. Source: FY2022 10-K, accession 0000320335-23-000008 (2020 column).
2019 $6.60 ▼
OE = CFO - dWC - SBC - maintenance capex (insurer treatment: policy liabilities and deferred acquisition costs are the working capital of a life insurer, so their cash-flow-statement movements are removed). CFO=$1363.9M. dWC = increase in future policy benefits 661.6 + other policy benefits 15.9 + deferral of policy acquisition costs (753.7) + DAC amortization 551.7 + change in current/deferred income taxes 68.6 = $544.1M. SBC=$44.8M. Capex=$42.2M; mean capex/revenue 2016-2025=0.979%; revenue $4527.5M vs prior-year $4303.8M so growth capex=$2.2M and maintenance capex=$40.0M. OE=$734.9M; diluted shares=111.38M; OE/sh=$6.60. Pre-LDTI accounting basis. Source: FY2019 10-K, accession 0000320335-20-000008.
2018 $5.43 ▼
OE = CFO - dWC - SBC - maintenance capex (insurer treatment: policy liabilities and deferred acquisition costs are the working capital of a life insurer, so their cash-flow-statement movements are removed). CFO=$1277.6M. dWC = increase in future policy benefits 665.0 + other policy benefits 17.1 + deferral of policy acquisition costs (699.6) + DAC amortization 516.7 + change in current/deferred income taxes 69.4 = $568.6M. SBC=$39.8M. Capex=$45.1M; mean capex/revenue 2016-2025=0.979%; revenue $4303.8M vs prior-year $4155.6M so growth capex=$1.5M and maintenance capex=$43.6M. OE=$625.6M; diluted shares=115.25M; OE/sh=$5.43. Pre-LDTI accounting basis. Source: FY2018 10-K, accession 0000320335-19-000006.
2017 $5.45 ▼
OE = CFO - dWC - SBC - maintenance capex (insurer treatment: policy liabilities and deferred acquisition costs are the working capital of a life insurer, so their cash-flow-statement movements are removed). CFO=$1429.1M. dWC = increase in future policy benefits 687.4 + other policy benefits 31.8 + deferral of policy acquisition costs (660.1) + DAC amortization 490.4 + change in current/deferred income taxes 176.3 (normalized: reported line is $(700.7)M, which includes the one-time non-cash $877M TCJA deferred-tax remeasurement benefit that did not affect CFO; -700.7+877.0=176.3) = $725.8M. SBC=$37.0M. Capex=$20.3M; mean capex/revenue 2016-2025=0.979%; revenue $4155.6M vs prior-year $3934.6M so growth capex=$2.2M and maintenance capex=$18.1M. OE=$648.1M; diluted shares=118.98M; OE/sh=$5.45. Pre-LDTI accounting basis. Source: FY2018 10-K, accession 0000320335-19-000006 (2017 column); TCJA $877M from FY2017 10-K accession 0000320335-18-000006.
2016 $5.66 ▼
OE = CFO - dWC - SBC - maintenance capex (insurer treatment: policy liabilities and deferred acquisition costs are the working capital of a life insurer, so their cash-flow-statement movements are removed). CFO=$1398.7M. dWC = increase in future policy benefits 645.8 + other policy benefits 24.7 + deferral of policy acquisition costs (635.3) + DAC amortization 469.1 + change in current/deferred income taxes 152.2 = $656.5M. SBC=$26.3M. Capex=$25.2M; mean capex/revenue 2016-2025=0.979%; revenue $3934.6M vs prior-year $3766.1M so growth capex=$1.6M and maintenance capex=$23.5M. OE=$692.4M; diluted shares=122.37M; OE/sh=$5.66. Pre-LDTI accounting basis. Source: FY2018 10-K, accession 0000320335-19-000006 (2016 column).

Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.

Sales geography
United States (all states; South, Midwest, Northeast and West, with a large base in Texas, Alabama and the Southeast), plus small amounts in Canada and New Zealand
Historical growth strategy
Organic growth through exclusive, commission-based agent networks (American Income Life, Liberty National, Family Heritage) that sell small-ticket life and supplemental health policies to middle-income and union families, plus a direct-to-consumer channel and a Medicare supplement business (United American). Growth comes from recruiting and retaining agents, steady renewal premium on policies that persist for years, and small bolt-on deals historically, with most surplus cash returned through share repurchases (diluted shares down from about 122 million in 2016 to about 79 million in 2026) rather than large acquisitions.
Chart analysis
A chartist would see a long, steady multi-year advance that was broken by a violent one-day collapse in April 2024 after a short-seller report, with the shares losing roughly half their value in a gap-down. The stock then spent 2024 and 2025 building a base above that gap and recovered a large part of the loss, a pattern chartists read as a V-shaped recovery with the post-collapse lows acting as major support and the pre-collapse highs as the main overhead resistance. After the second-quarter 2026 report in July 2026 the shares dropped roughly 8% in a day on an earnings-per-share miss; a chartist would watch whether that gap is filled quickly (a failed breakdown) or whether the shares fail at the rising long-term trend line and retest the 2025 consolidation range. The 2024 and 2026 gaps show how sensitive the shares are to headlines, and a sustained close back above the 2026 pre-earnings level would be viewed as bullish confirmation.
Competitors

Companies we consider competitors of GL. Tap a ticker to open our analysis of that company in a new tab.

Circle of competence

We don't have circle of competence information for this company yet.